AstraZeneca, Merck’s Lynparza wins EU nod in advanced prostate cancer right after FDA delay kdunleavy Wed, 12/21/2022 – 09:08 More: AstraZeneca, Merck's Lynparza wins EU nod in advanced prostate cancer right after FDA delay Source: fierce
read moreTamiflu generics in short supply in latest chapter of biopharma’s shortage saga fkansteiner Wed, 12/21/2022 – 08:40 More: Tamiflu generics in short supply in latest chapter of biopharma's shortage saga Source: fierce
read moreTherapy treats patients with metastatic non-small cell lung cancer and has completed successful phase 3 trial More: EQRx receives MHRA marketing approval for sugemalimab Source: News
read moreACD856 has also been shown across preclinical studies to improve cognition and memory More: AlzeCure’s promising Alzheimer’s abstract accepted Source: News
read more2023 forecast: As the COVID-19 vaccine market evolves, what’s next for the top players? zbecker Tue, 12/20/2022 – 13:48 More: 2023 forecast: As the COVID-19 vaccine market evolves, what's next for the top players? Source: fierce
read more2023 forecast: An ‘inflection point’ for biopharma, fueled by a flood of AI and machine learning products kdunleavy Tue, 12/20/2022 – 13:39 More: 2023 forecast: An 'inflection point' for biopharma, fueled by a flood of AI and machine learning products
read more© 1994 - 2026 B.M. Pharmaceuticals